173 related articles for article (PubMed ID: 12365798)
1. Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer.
Friedrich M; Axt-Fliedner R; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrath J
Histochem J; 2002; 34(1-2):35-40. PubMed ID: 12365798
[TBL] [Abstract][Full Text] [Related]
2. Heterodimer requirement for gene regulation by Vitamin D in variant OK cells.
Koszewski NJ; Rowan A
Steroids; 2003 Apr; 68(4):307-14. PubMed ID: 12787891
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
[TBL] [Abstract][Full Text] [Related]
4. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
[TBL] [Abstract][Full Text] [Related]
5. Modulation effects of zinc on the formation of vitamin D receptor and retinoid X receptor alpha-DNA transcription complexes: analysis by microelectrospray mass spectrometry.
Craig TA; Benson LM; Naylor S; Kumar R
Rapid Commun Mass Spectrom; 2001; 15(12):1011-6. PubMed ID: 11400211
[TBL] [Abstract][Full Text] [Related]
6. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
[TBL] [Abstract][Full Text] [Related]
7. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
8. Expression of vitamin D3 receptor and retinoid receptors in human breast cancer: identification of potential heterodimeric receptors.
Conde I; Paniagua R; Fraile B; Ruiz A; Arenas MI
Int J Oncol; 2004 Oct; 25(4):1183-91. PubMed ID: 15375571
[TBL] [Abstract][Full Text] [Related]
9. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
Matkovits T; Christakos S
Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
[TBL] [Abstract][Full Text] [Related]
10. 9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells.
Jääskeläinen T; Ryhänen S; Mäenpää PH
J Cell Biochem; 2003 Aug; 89(6):1164-76. PubMed ID: 12898515
[TBL] [Abstract][Full Text] [Related]
11. Retinoid-X-receptor-alpha-independent binding of vitamin D receptor to its response element from human osteocalcin gene.
Jääskeläinen T; Itkonen A; Mäenpää PH
Eur J Biochem; 1995 Mar; 228(2):222-8. PubMed ID: 7705332
[TBL] [Abstract][Full Text] [Related]
12. Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor.
Jin CH; Pike JW
Mol Endocrinol; 1996 Feb; 10(2):196-205. PubMed ID: 8825559
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
[TBL] [Abstract][Full Text] [Related]
14. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
Kephart DD; Walfish PG; DeLuca H; Butt TR
Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
[TBL] [Abstract][Full Text] [Related]
15. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
16. Expression of 1,25-dihydroxy vitamin D3 receptor in breast carcinoma.
Friedrich M; Rafi L; Tilgen W; Schmidt W; Reichrath J
J Histochem Cytochem; 1998 Nov; 46(11):1335-7. PubMed ID: 9774633
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
Fernandez-Martin JL; Kurian S; Farmer P; Nanes MS
Mol Cell Endocrinol; 1998 Jun; 141(1-2):65-72. PubMed ID: 9723887
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma.
Villena-Heinsen C; Meyberg R; Axt-Fliedner R; Reitnauer K; Reichrath J; Friedrich M
Anticancer Res; 2002; 22(4):2261-7. PubMed ID: 12174912
[TBL] [Abstract][Full Text] [Related]
19. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor.
Prüfer K; Barsony J
Mol Endocrinol; 2002 Aug; 16(8):1738-51. PubMed ID: 12145331
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
